Zeus Hygia has created one of the most advanced and scalable platform for improving solubility and bioavailability of poorly soluble actives, which eventually increases bio-eﬃcacy, potency, and bioavailability.
The goal of Zeus BioSOLVE Technology is to encapsulate water-insoluble bioactives in a food-grade water-soluble matrix using novel phase coacervation techniques. This technology helps to deliver actives in situ with increased hydrophillicity , larger surface area leading to better absorption and maximum efficacy. The carrier used in the encapsulation process are GRAS and widely used across the globe in food industry.
The uniqueness and differentiator of Zeus BioSOLVE Technology is that the process is driven by mono ingredient system.
The increase in water solubility with better dissolution properties, finer and uniform particles with larger surface area can be most likely considered as driving factors for improved bioavailability and efficacy.
Zeus BioSOLVE Technology has unique delivery capabilities which allow the bio-actives contained in the encapsulation matrix to improve solubility and bioavailability. This advanced technology opens up a wide array of opportunities and comes with multiple advantages that, with advanced research, this can be explored beyond nutraceutical domain.
ZeusHygia LifeSciences has developed proprietary platform BioFusion technology, which enables to encapsulate the range of bio actives with unique bio potentiator adopting encapsulation technology. ZeusHygia’s proprietary technology works on the principle of creating molecular dispersions of bio actives in safe and food grade media .The bio actives get encapsulated in food grade carriers and forms free flowing, uniform, micro-particulate structure. By employing the patented BioFusion technology It is possible to encapsulate the bioactive in the smallest, absolutely homogeneous units in the form of dry and/or liquid product forms.